Cite

HARVARD Citation

    Mastorino, L. et al. (2022). Risankizumab shows faster response in bio naïve than in bio‐experienced psoriatic patients. Journal of the European Academy of Dermatology and Venereology. pp. e838-e841. [Online]. 
  
Back to record